<DOC>
	<DOCNO>NCT01902784</DOCNO>
	<brief_summary>Research Protocol Abstract : This phase II control trial ( RCT ) `` storytelling '' intervention compare treatment among surrogate participate decision limit life-sustaining treatment ICU incapacitate love one . Subjects sequentially assign `` storytelling '' ( facilitated elicitation experience 2-4 week bereavement ) treatment follow `` monitoring well-being '' . Subjects receive print bereavement brochures 1 week , undergo telephone symptom assessment 2-weeks , 3-months , 6-months bereavement .</brief_summary>
	<brief_title>The Surrogate Project ( Surrogate Storytelling )</brief_title>
	<detailed_description />
	<criteria>Screening/Recontact ( 1st phase ) Eligible patient : lack decisionmaking capacity surrogate decision maker ( family member friend ) Eligible surrogate : 18 year age old selfidentify primary decisionmaking authority patient live within approximately 50miles less University Pittsburgh able conduct 1hr interview English Courtappointed power attorney exclude , expect experience emotional distress family member friend critically ill patient . For Assignment Intervention/Control ( 2nd phase ) Eligible surrogate : previously give consent study staff follow love one 's course hospital recontacted participated decision make limitation lifesustaining treatment ( LST ) love one ( ICU patient ) love one ( ICU patient ) die hospital Screening/Recontact Ineligible patient : less 18 year old prisoner legal concern , malpractice Ineligible surrogate : less 18 year old unable complete 1hour interview questionnaire English For Assignment Intervention/Control Ineligible patient : fully permanently regain decisionmaking capacity therefore longer require surrogate make treatment decision discharge hospital alive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Intensive Care Unit patient family</keyword>
	<keyword>Surrogate decision making</keyword>
	<keyword>Life Sustaining Treatments ( LST )</keyword>
</DOC>